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Cancer leaves important consequences in the shape, function and esthetics of 
the patient, especially when it is cancer of the oral cavity or upper aero-digestive 
tract. Although reconstruction with local and microvascular flaps is sometimes 
a viable option, maxillofacial rehabilitation with osseointegrated implants is a 
well-reported treatment alternative with a high success rate. The main advantages 
in this modality of rehabilitation are the decrease in biological and economic costs, 
simplifying the management of these defects by reducing surgical intervention, 
hospitalization time, postoperative morbidity and treatment time. There are several 
classification systems; however, there is no classification system that has accurately 
described the maxillofacial defect under a surgical, prosthetic and reconstructive 
approach with osseointegrated implants. The purpose of this study is to guide pro-
fessionals in decision-making for maxillofacial rehabilitation using osseointegrated 
implants located in the anatomical buttresses of the maxillofacial region.
Keywords: dental implants, anatomical buttress, maxillectomy defects, maxillofacial 
rehabilitation, prosthodontic reconstruction
1. Introduction
In 2018, The Global Cancer Statistics reported just over 18 million new cases 
worldwide. Lip and oral cavity cancer is ranked 18th with 354,864 new cases (2.0%) 
and 177,384 deaths (1.9%). However, if we analyze the main cancers that affect the 
upper digestive tract (salivary glands, hypopharynx, oropharynx, nasopharynx, 
larynx, lip, and oral cavity), we obtain approximately 887,659 new cases (4.9%) of 
cancers that could leave important sequelae in the maxillofacial region [1].
Maxillectomy is defined as the partial or total surgical removal of the maxilla 
and was designed as a surgical treatment for tumors that affect the middle third 
of the face. During oncological ablative surgery complex maxillofacial defects 
result that involve the loss of anatomical structures such as dental elements, facial 
cavities, sense organs, bone tissue and facial soft tissue. Although reconstruction 
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with local and microvascular flaps is sometimes a viable alternative, maxillofacial 
rehabilitation with osseointegrated implants has been a well-reported treatment 
with a high success rate. [2]
Various techniques and anatomical locations have been described in the facial 
region for the placement of osseointegrated implants and its reason is based on the 
bone buttress where a skeletal anchorage is possible to support the functional load of 
the implants. In general, maxillofacial rehabilitation with osseointegrated implants 
uses anchors in the zygomatic, pterygoid, nasomaxillary and alveolar zones [3–5].
2. Buttress implant concept and classification
Based on the anatomical zones of the bony buttresses of the facial middle third, 
we designed a classification system that allows determining the therapeutic options 
where the placement and functional loading of osseointegrated implants is feasible: 
zone I or alveolar, zone II or nasomaxillary, zone III or zygomatic, zone IV or 
pterygoid (Figure 1).
2.1 Zone I/maxillary alveolar buttress
2.1.1 Tilted and axially positioned implants
The use of endosseous osseointegrated implants was introduced to North 
America in 1982. At that conference, Branemark presented the data from 15 years of 
work, which was highly evidence-based with long-term clinical follow-up findings 
setting the guidelines for contemporary implantology [6].
Currently implantology has improved considerably; dental implants have incor-
porated advances in their anatomy, surface and types of connections, achieving a 
higher success rate and predictable results [7, 8].
Implants angled between 30 and 45° were described as an alternative surgical 
technique in order to avoid nearby anatomical structures or to achieve an adjacent 
bone position. Thus, we avoid advanced bone regeneration procedures and mini-
mize the cantilever of prosthetic rehabilitation [9].
Figure 1. 
Anatomical zones of the bony buttresses of the facial middle third and placement of osseointegrated implants 
with their positions in the prosthetic arch.
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2.1.2 Nasopalatine implants
In 1994 Scher. describes the use of the nasopalatine canal as a receptor site for a 
dental implant, since then controlled studies have been carried out that confirm its 
viability for the functional load of osseointegrated implants [10].
Peñarrocha et al. treated 13 patients with 78 osseointegrated implants in the 
rehabilitation of the atrophic maxilla. Of 78 implants, 13 were implanted in the 
nasopalatine canal, 6 patients had reversible sensory alteration, and 2 implants 
failed in healthy patients, yielding a success rate of 84.6% [11].
Occasionally, when performing a partial maxillectomy, bone is available 
throughout the Maxillary alveolar buttress. In these cases, it is possible to use 
conventional dental implants anchored even in contralateral anatomical structures.
2.2 Zone II/nasomaxillary buttress
2.2.1 Nasomaxillary implants
Although the term “Nasomaxillary implant” has not been defined in the 
Glossary of Oral and Maxillofacial Implants (GOMI) [12]. We define it as “Implant 
placement through the alveolar process and into the nasomaxillary buttress”.
The nasomaxillary buttress has been well described in facial trauma as it is a 
key anatomic zone in the reconstruction of fractures of the middle third. This area 
offers a cortical bone suitable for the anchorage and functional load of osseointe-
grated implants. However, there are few implant-oriented anatomical studies and 
some are anthropometric studies [13–16].
Some authors have described the placement of posterior tilted implants between 
30 and 45° that reach an apical anchorage in the nasomaxillary buttress [9, 17, 18]. 
However, this type of implant is not frankly a nasomaxillary implant because they 
are retained from an apical portion and are not strictly into the buttress as in the 
case of a long implant with an axial orientation.
Nasomaxillary implants can be used as an anchorage point in a location anterior 
to the prosthetic arch. With this, we achieve anterior stability and the reduction of 
work forces in posterior implants.
2.3 Zone III/zygomaticomaxillary buttress
2.3.1 Zygomatic implants
In 1998 Dr. P. I Branemark described zygomatic implants as a bone anchorage 
alternative with a design between 30 and 52.5 mm long that are inserted into the body 
of the malar bone [19]. Since then, Branemark and other authors have described various 
surgical techniques and approaches for zygomatic implant placement that could be used 
to rehabilitate atrophic jaws or in patients with partial or total maxillectomy [20–22].
Scott et al. rehabilitated 28 patients after undergoing rhinectomy for malignant 
pathological processes, a total of 56 zygomatic implants were used as retainers of 
maxillofacial prostheses, 1 failed after radiotherapy having a success rate of 98% in 
15 years [4].
In general, most authors agree that zygomatic implants are more than 95% suc-
cessful [23] and in radiated patients the success rate of implants is highly variable 
with a range between 72 and 98% [2].
Zygomatic implants offer adequate bone quality and quantity. Sometimes when the 
maxillectomy is extensive, it compromises the malar bone. Performing regenerative 
procedures with autografts or xenografts are a viable option to improve site conditions.
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2.4 Zone IV/pterygomaxillary buttress
2.4.1 Pterygomaxillary implants
Tulasne and Tessier in 1989 were the first to describe the technique for the place-
ment of pterygoid implants [24]. This technique wanted to resolve the difficulties 
caused by the presence of the maxillary sinus and the poor characteristics of the 
bone in the maxillary tuberosity.
Pterygoid implants are implants between 15 and 20 mm long that allow a bone 
anchorage of up to 9 mm in the pterygoid process [25]. However, in the maxilecto-
mized patient this length may vary because the posterior segment of the maxilla is 
not found.
Araujo et al. in 2019 performed a systematic review from January 1995 to 
January 2018. A total of 634 patients received 1893 pterygoid implants, with a 
10-year survival rate of 94.85%.
Pterygoid implants are a viable option and if their main advantage is to decrease 
the prosthetic distal cantilever [26].
3. Buttress implant concept: advantages and disadvantages
Maxillofacial reconstruction with osseointegrated implants placed in bony 
buttresses is indicated in patients who have suffered loss of mid-facial anatomical 
structures due to benign and malignant pathological processes, trauma, and severe 
maxillary atrophy.
There are few contraindications to the use of osseointegrated implants and they 
are mostly relative. Their reason is that they decrease the success rate compared to 
implantation in healthy patients. The most important contraindications suggest bone 
healing disorders such as bisphosphonate treatment, radiotherapy, chemotherapy 
and active infection. However, for each situation there are protocols that help main-
tain a high success rate and some of them are discussed in this chapter [20, 23, 27].
The main advantages in this type of rehabilitation are the decrease in the number 
of reconstructive surgeries, avoiding the use of donor sites and a shorter hospital 
stay. By performing a single-phase reconstruction, the patient recovers the phona-
tion, swallowing and chewing lost due to the oncological defect. in addition, the 
patients present a timely and less morbid treatment compared to local and microvas-
cular grafts. To achieve these results, prosthetically guided reconstruction is key [28].
4. Virtual prosthetic and surgical planning
Three-dimensional (3D) planning in oral and maxillofacial surgery has 
become a standard in the treatment of multiple conditions of the facial region. 
Multiple Programs have been designed to perform 3D virtual planning and 
surgery in the reconstruction with osseointegrated implants (DTX Studio 
Implant®, SIMPLANT®, DDS-pro®, 3Shape Dental System®). Most of them 
are equipped with numerous software complements that allow the preparation 
of surgical guides and prosthetic reconstructions with different attachments 
through CAD/CAM [29].
Some of the multiple advantages offered by 3D virtual surgery are: simulating 
different approaches and types of procedures, avoiding damage to neurovascular 
and anatomical structures, reducing operating time and improving postoperative 
recovery, reducing complications and obtaining more predictable results.
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For preoperative evaluation and planning, a CT scan of the head and neck is the 
Gold standard [3, 23]. The planning of the placement of osseointegrated implants 
must be prosthetically guided. This means that planning must precede the surgical 
act of implant placement and these must be located where it best suits prosthetic 
rehabilitation and biomechanical demands. The objective should be a surgical and 
prosthetic planning with at least four osseointegrated implants with their distrib-
uted emergencies in a polygonal manner over the prosthetic arch. In this way, we 
were able to tripodize and stabilize the prosthetic reconstruction in the face of the 
functional demands of chewing (Figure 2) [28, 30].
5. Simulated surgery in stereolithographic biomodels
Stereolithography is a solid three-dimensional prototype obtained through the 
processing of data obtained from computed tomography or magnetic resonance 
imaging. In recent years, stereolithographic manufacturing has made great strides 
in the quality, resolution, and precision of manufactured parts and is becoming 
increasingly important in medicine and surgery [31].
Figure 2. 
3-dimensional computed prosthetic and surgical planning and bone availability in the peri-implant 
anatomical zone.
Figure 3. 
Simulated surgery in stereolithographic biomodel. Zygomatic and Pterygomaxillary implants placed in the 
planned positions.
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Three-dimensional printing has been used to produce anatomical models, 
surgical guides and templates, implants, and molds. The main advantages include: 
the possibility of preoperative planning, the precision of the process used and the 
time saved in the operating room. However, other studies report inconsistency in 
precision and additional costs in treatment [32].
The maxillofacial reconstruction with osseointegrated implants simulated in 
a biomodel, allows to determine the lengths and final positions of the implants, 
prepare the surgeon for the surgical procedure and minimize the possibilities of 
errors favoring the results of the treatment (Figures 3 and 4).
6. Prosthetic and facial reconstruction
Oral and facial deformity can cause functional and psychological deterioration 
in oncological patients. The aims of prosthodontic reconstruction are the rehabilita-
tion of the shape, function and esthetics of the lost anatomical structures by means 
of artificial substitutes. The main facial subunits that require reconstruction due 
to malignant pathological processes involve the ear, forehead, eyes and brow, nose, 
check, lips and chin [33].
Currently, there are multiple workflows where they combine conventional 
prosthetic preparation with the use of facial scanners and custom 3D impressions 
Figure 4. 
Photograph of surgical field after placement of zygomatic and Pterygomaxillary implants.
Figure 5. 
Photograph showing implant-supported obturator placed and final photograph.
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that allow the direct or indirect manufacture of definitive maxillofacial prostheses 
from conventional silicone [34, 35].
The main advantage with dental prosthodontic reconstruction is the adaptation of a 
retained implant obturator that allows a posterior palatal seal. With this, most patients 
successfully recover phonation, swallowing, and chewing function. Artificial facial 
prostheses allow us to better characterize the demanding anatomy of the face. In most 
cases, the retention of facial prostheses occurs when copying the anatomical defect, on 
other occasions magnetized attachments can be used in prosthetic reconstruction or 
protective glasses that also improve the characterization of the face (Figure 5).
7. Radiotherapy treatment and implants
In early clinical stages, surgery is the first decision. However, adjuvant radio-
therapy is sometimes indicated in cases of close excision margins (<5 mm), 
involved (<1 mm), and in suspicion or confirmation of lymph node metastasis with 
or without extracapsular extension [36]. In general, radiation therapy includes 
conventional radiation therapy or intensity modulated radiation therapy (IMRT). 
The latter is more convenient by precisely targeting radiation to a specific area 
and reducing the dose to nearby anatomical structures such as malar bone, grafts, 
implants, salivary glands, eyes, and spinal cord [37].
Schiegnitz’s study suggests that radiation negatively affects implant survival, but 
there is no statistically significant difference in survival when implants are inserted 
12 months before or after radiation therapy. [38] Other authors have shown favorable 
results. With implantation at least 6 weeks before radiotherapy since there is a surgi-
cal area with less hypoxia, hypovascularity and hypocellularity [27, 39] (Figure 6).
8. Chemotherapy treatment and implants
Systemic antineoplastic therapy includes induction, neoadjuvant, adjuvant, and 
palliative therapy [40]. The survival rate of osseointegrated implants in the patient 
with antineoplastic and antiangiogenic therapy has not yet been elucidated. Controlled 
animal studies have shown negative effects on the osseointegration process with 
 chemotherapeutic regimens with cisplatin, bevacizumab and sunitinib [41–43]. 
However, retrospective studies in humans have reported that chemotherapy has no 
detrimental effects on the osseointegration and functional stability of dental implants. 
The success rates reported by these studies were 97.6 and 99.1% [44–46].
Figure 6. 
Histogram showing trajectories, dose and volume used for adjuvant radiotherapy.
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9. Conclusion
The placement of osseointegrated implants in anatomical buttresses of the upper 
jaw is a predictable treatment with a high success rate. By reconstructing the lost 
anatomical structures with artificial substitutes, a better characterization of the 
face is achieved and an important esthetic defect is covered with acceptable results.
The main advantages in this modality of reconstruction include the decrease in 
surgical times, hospital stay and postoperative morbidity. By rehabilitating phona-
tion, swallowing and masticatory function, we improve the quality of life and social 
reintegration of the oncological patient.
Currently, technological advances point to the development in the design of custom-
ized implants; however, controlled studies are required to evaluate the use and behavior 
of these implants in the different scenarios presented by the oncological patient.
Acknowledgements
To the National Cancer Institute - Mexico City and the head and neck medical 
department for the comprehensive treatment of oncological patients. To Dr. Víctor 
Felipe Orduña López for the joint treatment.
Conflict of interest
There are no conflicts of interest to declare.
Ethical approval
Institutional approval was not required.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
9A Review of Maxillofacial Rehabilitation Using Osseointegrated Implants in Oncological…
DOI: http://dx.doi.org/10.5772/intechopen.93224
[1] Bray F, Ferlay J, Soerjomataram I, 
Siegel RL, Torre LA, Jemal A. Global 
cancer statistics 2018: GLOBOCAN 
estimates of incidence and mortality 
worldwide for 36 cancers in 185 
countries. CA: A Cancer Journal for 
Clinicians. 2018;68(6):394-424
[2] Gómez-Pedraza A, González-Cardín V, 
Díez-Suárez L, Herrera-Villalva M. 
Maxillofacial rehabilitation with 
zygomatic implants in an oncologic 
patient: A case report. Journal of Oral  
and Maxillofacial Surgery. 2020;78(4): 
547-556. DOI: 10.1016/j.joms.2019.10.006
[3] Pellegrino G, Tarsitano A, Basile F, 
Pizzigallo A, Marchetti C. Computer-
aided rehabilitation of maxillary 
oncological defects using zygomatic 
implants: A defect-based classification. 
Journal of Oral and Maxillofacial 
Surgery. 2015;73(12):2446.e1-2446.e11. 
DOI: 10.1016/j.joms.2015.08.020
[4] Scott N, Kittur MA, Evans PL, 
Dovgalski L, Hodder SC. The use of 
zygomatic implants for the retention of 
nasal prosthesis following rhinectomy: 
The Morriston experience. International 
Journal of Oral & Maxillofacial Surgery. 
2016;45(8):1044-1048. DOI: 10.1016/j.
ijom.2016.01.020
[5] Vrielinck L, Politis C, Schepers S,  
Pauwels M, Naert I. Image-based 
planning and clinical validation 
of zygoma and pterygoid implant 
placement in patients with severe bone 
atrophy using customized drill guides. 
Preliminary results from a prospective 
clinical follow-up study. International 
Journal of Oral and Maxillofacial 
Surgery. 2003;32(1):7-14
[6] Block MS. Dental implants: The 
last 100 years. Journal of Oral and 
Maxillofacial Surgery. 2018;76(1):11-26
[7] Ogle OE. Implant surface material, 
design, and osseointegration. 
Dental Clinics of North America. 
2015;59(2):505-520. DOI: 10.1016/j.
cden.2014.12.003
[8] Smeets R, Stadlinger B, Schwarz F, 
Beck-Broichsitter B, Jung O, Precht C, 
et al. Impact of dental implant surface 
modifications on osseointegration. 
BioMed Research International. 
2016;2016:6285620. DOI: 
10.1155/2016/6285620
[9] Soto-Peñaloza D, Zaragozí-Alonso R,  
Peñarrocha-Diago M, Peñarrocha- 
Diago M. The all-on-four treatment 
concept: Systematic review. Journal of 
Clinical and Experimental Dentistry. 
2017;9(3):e474–e488
[10] Scher E. Use of the incisive canal as 
a recipient site for root form implants: 
Preliminary clinical reports. Implant 
Dentistry. 1994;3:38-41
[11] Peñarrocha D, Candel E, Guirado JL, 
Canullo LPM. Implants placed in the 
nasopalatine canal to rehabilitate 
severely atrophic maxillae: A 
retrospective study with long follow-up. 
The Journal of Oral Implantology. 
2014;40(6):699-706
[12] Laney W. Oral and endorsing 
organizations. The International Journal 
of Oral & Maxillofacial Implants. 
2017;32:Gi-G200
[13] McCollum MA. Nasomaxillary 
remodeling and facial form in robust 
australopithecus: A reassessment. 
Journal of Human Evolution. 
2008;54(1):2-14
[14] Hwang TS, Song J, Yoon H, 
Cho BP, Kang HS. Morphometry of 
the nasal bones and piriform apertures 
in Koreans. Annals of Anatomy. 
2005;187(4):411-414
[15] Adnot J, Desbarats C, Joly LM, 
Trost O. Nasomaxillary fracture: 
References
Oral and Maxillofacial Surgery
10
Retrospective review of 11 consecutive 
patients and literature review. Journal 
of Stomatology, Oral and Maxillofacial 
Surgery. 2019;120(6):534-539. DOI: 
10.1016/j.jormas.2019.03.003
[16] Hsiao S, Cheng J, Tseng Y.  
ScienceDirect nasomaxillary and 
mandibular bone growth in primary 
school girls aged 7 to 12 years. The 
Internet Journal of Dental Science. 
2020;xxxx:3-8. DOI: 10.1016/j.
jds.2020.03.010
[17] Jensen OT. Dental extraction, 
immediate placement of dental 
implants, and immediate function. 
Oral and Maxillofacial Surgery Clinics 
of North America. 2015;27(2):273-282. 
DOI: 10.1016/j.coms.2015.01.008
[18] Jensen OT, Adams MW, Butura C, 
Galindo DF. Maxillary V-4: Four implant 
treatment for maxillary atrophy with 
dental implants fixed apically at the 
vomer-nasal crest, lateral pyriform rim, 
and zygoma for immediate function. 
Report on 44 patients followed from 1 to 
3 years. Journal of Prosthetic Dentistry. 
2015;114, 6:810-817. DOI: 10.1016/j.
prosdent.2014.11.018
[19] Branemark P. Surgery Fixture 
Installation: Zygomaticus Fixture 
Clinical Procedures. 1st ed. Gotemburgo, 
Suecia: Nobel Bio- care, AB; 1998
[20] Salem AA, Shakel EA, Sadakha AA, 
Kassem EM, El-Segai AA. Evaluation 
of Zygomatic implant retained 
obturator in rehabilitation of partial 
palato-maxillectomy patients. Tanta 
Dental Journal. 2015;12(1):35-40. DOI: 
10.1016/j.tdj.2014.10.003
[21] Rosenstein J, Dym H. Zygomatic 
implants: A solution for the atrophic 
maxilla. Dental Clinics of North 
America. 2020;64(2):401-409. DOI: 
10.1016/j.cden.2019.12.005
[22] King E, Abbott C, Dovgalski L, 
Owens J. Orofacial rehabilitation with 
zygomatic implants: CAD-CAM bar 
and magnets for patients with nasal 
cancer after rhinectomy and partial 
maxillectomy. Journal of Prosthetic 
Dentistry. 2017;117(6):806-810. DOI: 
10.1016/j.prosdent.2016.09.029
[23] Aparicio C, Ouazzani W, Hatano N. 
The use of zygomatic implants for 
prosthetic rehabilitation of the severely 
resorbed maxilla. Periodontology 2000. 
2000;47(1):162-171
[24] Tulasne JF. Implant treatment 
of missing posterior dentition. In: 
Albrektson T, Zarb G, editors. The 
Branemark Osseointegrated Implant. 
Chicago: Quintessence; 1989. p. 103-115
[25] Bidra AS, Huynh-Ba G. Implants 
in the pterygoid region: A systematic 
review of the literature. International 
Journal of Oral and Maxillofacial 
Surgery. 2011;40(8):773-781. DOI: 
10.1016/j.ijom.2011.04.007
[26] Araujo RZ, Santiago Júnior JF, 
Cardoso CL, Benites Condezo AF, 
Moreira Júnior R, Curi MM. Clinical 
outcomes of pterygoid implants: 
Systematic review and meta-analysis. 
Journal of Cranio-Maxillofacial Surgery. 
2019;47(4):651-660. DOI: 10.1016/j.
jcms.2019.01.030
[27] Schepers RH, Slagter AP, 
Kaanders JHAM, van den Hoogen FJA, 
Merkx MAW. Effect of postoperative 
radiotherapy on the functional result of 
implants placed during ablative surgery 
for oral cancer. International Journal 
of Oral and Maxillofacial Surgery. 
2006;35(9):803-808
[28] Okay DJ, Genden E, Buchbinder D, 
Urken M. Prosthodontic guidelines for 
surgical reconstruction of the maxilla. 
The Journal of Prosthetic Dentistry. 
2001;86(4):352-363
[29] Surovas A. A digital workflow for 
modeling of custom dental implants. 3D 
11
A Review of Maxillofacial Rehabilitation Using Osseointegrated Implants in Oncological…
DOI: http://dx.doi.org/10.5772/intechopen.93224
Printing in Medicine. 2019;5(9):01-11. 
DOI: 10.1186/s41205-019-0046-y
[30] Wentaschek S, Lehmann K, 
Scheller H, Weibrich G, Behneke N. 
Polygonal area of prosthesis support 
with straight and tilted dental 
implants in edentulous maxillae. The 
International Journal of Prosthodontics. 
2016;29(3):245-252
[31] Raman R, Bashir R. 
Stereolithographic 3D bioprinting for 
biomedical applications. In: Essentials 
of 3D Biofabrication and Translation. 
Elsevier Inc.; 2015. pp. 89-121. DOI: 
10.1016/B978-0-12-800972-7/00006-2
[32] Martelli N, Serrano C, Van Den 
Brink H, Pineau J, Prognon P, Borget I, 
et al. Advantages and disadvantages 
of 3-dimensional printing in surgery: 
A systematic review. Surgery. 
2016;159(6):1485-1500
[33] Garritano FG, Fedok F. Facial 
reconstruction after resection for 
cutaneous malignancies. Operative 
Techniques in Otolaryngology. 
2013;24(1):36-44. DOI: 10.1016/j.
otot.2013.03.002
[34] Unkovskiy A, Spintzyk S, 
Brom J, Huettig F, Keutel C. Direct 3D 
printing of silicone facial prostheses: 
A preliminary experience in digital 
workflow. Journal of Prosthetic 
Dentistry. 2018;120(2):303-308. DOI: 
10.1016/j.prosdent.2017.11.007
[35] McHutchion L, Aalto D. Simulation 
of tissue-prosthesis margin interface 
by using surface scanning and digital 
design for auricular prostheses. Journal 
of Prosthetic Dentistry. 2020:1-12. DOI: 
10.1016/j.prosdent.2020.01.045
[36] Ellis MA, Graboyes EM, 
Wahlquist AE, Neskey DM, Kaczmar JM, 
Schopper HK, et al. Primary surgery vs. 
radiotherapy for early stage oral cavity 
cancer. Otolaryngology–Head and Neck 
Surgery. 2018;158(4):649-659
[37] Brennan PA, Bradley KL, Brands M. 
Intensity-modulated radiotherapy in 
head and neck cancer — An update 
for oral and maxillofacial surgeons. 
British Journal of Oral and Maxillofacial 
Surgery. 2017;55(8):770-774. DOI: 
10.1016/j.bjoms.2017.07.019
[38] Schiegnitz E, Al-Nawas B,  
Kämmerer PW, Grötz KA. Oral 
rehabilitation with dental implants in 
irradiated patients: A meta-analysis 
on implant survival. Clinical Oral 
Investigations. 2014;18(3):687-698
[39] Zen Filho EV, Tolentino EDS, 
Santos PSS. Viability of dental implants 
in head and neck irradiated patients: 
A systematic review. Head & Neck. 
2016;38:E2229–E2240
[40] Granados M, Arrieta O, Cantú de 
León D. Oncología y cirugía. In: Bases 
y principios. 1a ed. México: Manual 
Moderno; 2013. p. 768. Available 
from: https://books.google.com/
books?id=xWTLCQAAQBAJ&pgis=1
[41] Al-Jandan B, Marei HF,  
Abuohashish H, Zakaria O, 
Al-Mahalawy H. Effects of sunitinib 
targeted chemotherapy on the 
osseointegration of titanium implants. 
Biomedicine & Pharmacotherapy. 
2018;100(January):433-440
[42] Al-Jandan B, Marei HF,  
Abuohashish H, Zakaria O, 
Al-Mahalawy H. Effects of cisplatin 
chemotherapy on the osseointegration 
of titanium implants. Biomedicine & 
Pharmacotherapy. 2018;100:433-440
[43] Al-Jandan B. Effect of 
antiangiogenic targeted chemotherapy 
on the osseointegration of titanium 
implants in rabbits. The British Journal 
of Oral & Maxillofacial Surgery. 
2019;57(2):157-163
[44] Javed F, Al-Hezaimi K, 
Al-Rasheed A, Almas K, Romanos GE. 
Implant survival rate after oral cancer 
therapy: A review. Oral Oncology. 




[45] Kovács AF. Influence of 
chemotherapy on endosteal implant 
survival and success in oral cancer 
patients. International Journal of 
Oral and Maxillofacial Surgery. 
2001;30(2):144-147
[46] Kovács AF. The fate of 
osseointegrated implants in patients 
following oral cancer surgery and 
mandibular reconstruction. Head & 
Neck. 2000;22(2):111-119
